Similar articles

• Suppression of thyrotropin (h-TSH) in serums of patients with myxedema of varying etiology treated with thyroid hormones.

  Cotton GE, Gorman CA, Mayberry WE. Cotton GE, et al. N Engl J Med. 1971 Sep 2;285(10):529-33. doi: 10.1056/NEJM197109022851001. N Engl J Med. 1971. PMID: 5109216 No abstract available.
• A recurrent mass on the big toe.

  Renne SL, Valeri M, Radaelli S, Collini P, Barisella M. Renne SL, et al. Lancet Diabetes Endocrinol. 2020 Oct;8(10):868. doi: 10.1016/S2213-8587(20)30309-0. Lancet Diabetes Endocrinol. 2020. PMID: 32946823 No abstract available.
• Myxedema coma.

  Wartofsky L. Wartofsky L. Endocrinol Metab Clin North Am. 2006 Dec;35(4):687-98, vii-viii. doi: 10.1016/j.ecl.2006.09.003. Endocrinol Metab Clin North Am. 2006. PMID: 17127141 Review.
• Factors affecting resolution of pericardial effusions in primary hypothyroidism: a clinical, biochemical and echocardiographic study.

  Khaleeli AA, Memon N. Khaleeli AA, et al. Postgrad Med J. 1982 Aug;58(682):473-6. doi: 10.1136/pgmj.58.682.473. Postgrad Med J. 1982. PMID: 7134084 Free PMC article.
• Myxedema coma: diagnosis and treatment.

  Wall CR. Wall CR. Am Fam Physician. 2000 Dec 1;62(11):2485-90. Am Fam Physician. 2000. PMID: 11130234 Review.